{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:02:44Z","timestamp":1762866164144},"reference-count":5,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1097\/sga.0b013e31828a02a0","type":"journal-article","created":{"date-parts":[[2013,4,2]],"date-time":"2013-04-02T15:33:05Z","timestamp":1364916785000},"page":"140-142","source":"Crossref","is-referenced-by-count":2,"title":["RIFAXIMIN"],"prefix":"10.1097","volume":"36","member":"276","reference":[{"issue":"8","key":"R1-9-20210207","doi-asserted-by":"crossref","first-page":"767","DOI":"10.3748\/wjg.v18.i8.767","article-title":"Rifaximin vs. conventional oral therapy for hepatic encephalopathy: A meta-analysis.","volume":"18","author":"Karim","year":"2012","journal-title":"World Journal of Gastroenterology"},{"issue":"1","key":"R2-9-20210207","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0168-8278(02)00350-1","article-title":"Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: Results of a randomized, double-blind, double-dummy, controlled clinical trial.","volume":"38","author":"Mas","year":"2003","journal-title":"Journal of Hepatology"},{"issue":"1","key":"R3-9-20210207","first-page":"34","article-title":"Effect of rifaximin and paromomycin in the treatment of portal-systemic encephalopathy. Current Therapeutic Research.","volume":"52","author":"Parini","year":"1992","journal-title":""},{"issue":"4","key":"R4-9-20210207","first-page":"175","article-title":"Rifaximin versus neomycin on hyperammoniemia in chronic portal systemic encephalopathy of cirrhotics: A double-blind, randomized trial.","volume":"23","author":"Pedretti","year":"1991","journal-title":"Italian Journal of Gastroenterology"},{"issue":"suppl 1","key":"R5-9-20210207","first-page":"S10","article-title":"Rifaximin, a nonabsorbed oral antibiotic, in the treatment of hepatic encephalopathy: Antimicrobial activity, efficacy and safety.","volume":"5","author":"Williams","year":"2005","journal-title":"Reviews in Gastroenterological Disorders"}],"container-title":["Gastroenterology Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/SGA.0b013e31828a02a0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T06:07:29Z","timestamp":1620972449000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001610-201303000-00009"}},"subtitle":["A NONSYSTEMIC ANTIBIOTIC FOR HEPATIC ENCEPHALOPATHY"],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":5,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/sga.0b013e31828a02a0","relation":{},"ISSN":["1042-895X"],"issn-type":[{"value":"1042-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}